Perspective Therapeutics Updates Corporate Presentation

What Happened

• On September 8, 2026, Perspective Therapeutics, Inc. (NASDAQ: CATX) filed a Current Report on Form 8-K under Item 8.01 to announce an updated corporate presentation. A copy of the presentation is attached as Exhibit 99.1 and is incorporated by reference. The filing was signed by Joel Sendek, Chief Financial Officer.

Key Details

• Filing date: September 8, 2026.
• Item reported: 8.01 (Other Events) — updated corporate presentation filed as Exhibit 99.1.
• Exhibits listed: 99.1 (Corporate Presentation) and 104 (Interactive XBRL cover page).
• Signed by: Joel Sendek, Chief Financial Officer.

Why It Matters

• Updated corporate presentations often provide refreshed investor materials (strategy, clinical or product updates, timelines) that can affect investor perception. Investors should review Exhibit 99.1 to see any substantive changes.
• This 8-K does not report earnings, revenue, quarterly results, executive (CEO) changes, mergers, acquisitions, or material financial statements—its scope is limited to the presentation update.